放射肿瘤学在前列腺癌全程管理中的不断扩展作用
本文综述放疗在前列腺癌不同疾病阶段的应用:局限期根据初始风险分层等因素选择放疗方式、剂量与分割方案;局部区域复发时作为挽救治疗;转移期用于新发低瘤负荷转移的前列腺原发灶放疗、寡复发转移的转移灶定向治疗及晚期症状性转移的姑息治疗,并强调影像在临床决策、放疗计划与实施中的作用。
要点
- 局限期前列腺癌放疗方式、剂量与分割由初始风险分层及其他临床因素决定。
- 放疗可用于既往根治性放疗或手术后的局部区域复发挽救治疗。
- 转移期放疗包括新发低瘤负荷转移的前列腺原发灶放疗、寡复发转移的转移灶定向治疗及晚期症状性转移的姑息治疗。
核心结论
- 放疗贯穿前列腺癌局限期、局部区域复发与转移各阶段,影像在临床推理、放疗计划与治疗实施中起重要作用。
研究设计与样本
- 综述,总结放疗在前列腺癌根治性、局部区域复发和转移各阶段的作用及影像的作用。
临床应用与阅片要点
- 局限期选择放疗方式、剂量与分割时需结合初始风险分层与其他临床因素。
- 局部区域复发者(既往接受过根治性放疗或手术)放疗可作为挽救治疗选项。
- 转移期放疗应用包括新发低瘤负荷转移的前列腺原发灶放疗、寡复发转移的转移灶定向治疗及晚期症状性转移的姑息治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Radiotherapy is used in the treatment of prostate cancer in a variety of disease states with significant reliance on imaging to guide clinical decision-making and radiation delivery. In the definitive setting, the choice of radiotherapy treatment modality, dose, and fractionation for localized prostate cancer is determined by the patient's initial risk stratification and other clinical considerations. Radiation is also an option as salvage therapy in patients with locoregionally recurrent disease after prior definitive radiation or surgery. In recent years, the role of radiation has expanded for patients with metastatic disease, including prostate-directed radiotherapy in de novo low volume metastatic disease, metastasis-directed therapy for oligorecurrent disease, and palliative management of symptomatic metastases in the advanced setting. Here we review the expanding role of radiation in the treatment of prostate cancer in the definitive, locoregionally recurrent, and metastatic settings, as well as highlight the role of imaging in clinical reasoning, radiation planning, and treatment delivery.
引用
- Swensen S, Liao JJ, Chen JJ, et al. The expanding role of radiation oncology across the prostate cancer continuum. Abdom Radiol (NY). 2024. PMID: 38900319. doi:10.1007/s00261-024-04408-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。